doxazosin 1mg tablets
phoenix healthcare distribution ltd - doxazosin mesilate - oral tablet - 1mg
doxazosin mesilate tablets 8 mg
idt australia ltd - doxazosin mesilate, quantity: 9.704 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; indigo carmine aluminium lake; pregelatinised maize starch; iron oxide yellow; magnesium stearate - benign prostatic hyperplasia: for the treatment of both the urinary outflow obstruction and obstuctive and irritative symptoms associated with bph. hypertension: for the treatment of hypertension, either alone or in combination with diuretics, beta-adrenergic blocking agents, calcium chanel blockers, or angiotensin-converting enzyme inhibitors
doxazosin mesilate tablets 4 mg
idt australia ltd - doxazosin mesilate, quantity: 4.852 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; iron oxide red; microcrystalline cellulose; iron oxide yellow; pregelatinised maize starch; magnesium stearate - benign prostatic hyperplasia: for the treatment of both the urinary outflow obstruction and obstuctive and irritative symptoms associated with bph. hypertension: for the treatment of hypertension, either alone or in combination with diuretics, beta-adrenergic blocking agents, calcium chanel blockers, or angiotensin-converting enzyme inhibitors
doxazosin mesilate tablets 2 mg
idt australia ltd - doxazosin mesilate, quantity: 2.426 mg - tablet, uncoated - excipient ingredients: magnesium stearate; lactose monohydrate; microcrystalline cellulose; pregelatinised maize starch; iron oxide yellow - benign prostatic hyperplasia: for the treatment of both the urinary outflow obstruction and obstuctive and irritative symptoms associated with bph. hypertension: for the treatment of hypertension, either alone or in combination with diuretics, beta-adrenergic blocking agents, calcium chanel blockers, or angiotensin-converting enzyme inhibitors
doxazosin mesilate tablets 1 mg
idt australia ltd - doxazosin mesilate, quantity: 1.213 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; pregelatinised maize starch; lactose monohydrate; magnesium stearate - benign prostatic hyperplasia: for the treatment of both the urinary outflow obstruction and obstuctive and irritative symptoms associated with bph. hypertension: for the treatment of hypertension, either alone or in combination with diuretics, beta-adrenergic blocking agents, calcium chanel blockers, or angiotensin-converting enzyme inhibitors
doxazosin 2mg tablets
fannin (uk) ltd - doxazosin mesilate - oral tablet - 2mg
doxazosin 2mg tablets
waymade healthcare plc - doxazosin mesilate - oral tablet - 2mg
m-doxazosin
multichem nz limited - doxazosin mesilate 1.213mg equivalent to doxazosin 1 mg - tablet - 1 mg - active: doxazosin mesilate 1.213mg equivalent to doxazosin 1 mg excipient: colloidal silicon dioxide lactose monohydrate magnesium stearate microcrystalline cellulose sodium laurilsulfate sodium starch glycolate
m-doxazosin
multichem nz limited - doxazosin mesilate 2.426mg equivalent to doxazosin 2 mg - tablet - 2 mg - active: doxazosin mesilate 2.426mg equivalent to doxazosin 2 mg excipient: colloidal silicon dioxide lactose monohydrate magnesium stearate microcrystalline cellulose sodium laurilsulfate sodium starch glycolate
m-doxazosin
multichem nz limited - doxazosin mesilate 4.852mg equivalent to doxazosin 4 mg - tablet - 4 mg - active: doxazosin mesilate 4.852mg equivalent to doxazosin 4 mg excipient: colloidal silicon dioxide lactose monohydrate magnesium stearate microcrystalline cellulose sodium laurilsulfate sodium starch glycolate